• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

    69.86 +0.22 (+0.32%)
    Streaming Delayed Price Updated: 1:04 PM EDT, Apr 25, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 61,744
    Open 68.93
    Bid (Size) 69.86 (2)
    Ask (Size) 70.00 (1)
    Prev. Close 69.64
    Today's Range 68.93 - 70.00
    52wk Range 52.50 - 70.48
    Shares Outstanding 24,422,240
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
    Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Jazz Pharmaceuticals (NASDAQ:JAZZ) and its peers. 
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property
    ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings?
    Even during a down period for the markets, ANI Pharmaceuticals has gone against the grain, climbing to $68.06. Its shares have yielded a 16.1% return over the last six months, beating the S&P 500 by... 
    Via StockStory
    Topics Stocks Supply Chain
    Exposures Supply Chain US Equities

    Performance

    YTD
    +26.0%
    +26.0%
    1 Month
    +5.3%
    +5.3%
    3 Month
    +19.0%
    +19.0%
    6 Month
    +17.8%
    +17.8%
    1 Year
    +6.8%
    +6.8%

    More News

    Read More
    Deep Dive Into ANI Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
    Via Benzinga
    3 Russell 2000 Stocks in the Doghouse
    Via StockStory
    Where ANI Pharmaceuticals Stands With Analysts
    Via Benzinga
    A Peek at ANI Pharmaceuticals's Future Earnings
    Via Benzinga
    Critical Insights From ANI Pharmaceuticals Analyst Ratings: What You Need To Know
    Via Benzinga
    Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property
    Expert Outlook: ANI Pharmaceuticals Through The Eyes Of 4 Analysts
    Via Benzinga
    Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property
    1 Growth Stock to Target This Week and 2 to Avoid
    Via StockStory
    Exposures COVID-19
    Peeling Back The Layers: Exploring ANI Pharmaceuticals Through Analyst Insights
    Via Benzinga
    Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property
    Why Is ANI Pharmaceuticals (ANIP) Stock Soaring Today
    Via StockStory
    ANI Pharmaceuticals Expects Strong Start To 2025, On Back Of Cortrophin Gel And Generics, Lifts Annual Forecast
    Via Benzinga
    Get insights into the top gainers and losers of Friday's pre-market session.
    Via Chartmill
    ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Impressive Q4, Stock Soars
    Via StockStory
    Earnings Scheduled For February 28, 2025
    Via Benzinga
    Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property
    Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property
    Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property
    ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property
    Southwest Airlines, Silexion Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential
    Via Benzinga

    Frequently Asked Questions

    Is ANI Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, ANI Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does ANI Pharmaceuticals, Inc. - Common Stock trade on?
    ANI Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock is ANIP on the Nasdaq Stock Market
    What is the current price of ANI Pharmaceuticals, Inc. - Common Stock?
    The current price of ANI Pharmaceuticals, Inc. - Common Stock is 69.86
    When was ANI Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of ANI Pharmaceuticals, Inc. - Common Stock was at 04/25/25 01:04 PM ET
    What is the market capitalization of ANI Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of ANI Pharmaceuticals, Inc. - Common Stock is 1.71B
    How many shares of ANI Pharmaceuticals, Inc. - Common Stock are outstanding?
    ANI Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.